Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Covaxin

COVID Vaccine Approval Procedure Takes Longer Time: WHO official, As Covaxin decision awaited

Ryan was responding to a question during a recent virtual Q&A on whether there will be a definitive answer on Covaxin EUL by October 26.

Read More

WHO's Technical Group To Meet On Oct 26 To Consider Emergency Use Listing Of Covaxin

The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week.

Read More

WHO To Take Final Decision Next Week On Approval To Bharat Biotech's Covaxin

WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week, WHO said in a series of tweets.

Read More

Centre Got Over 65.25 Crore Covishield Doses, 9.1 Crore Covaxin Jabs Till September 19

The SII has informed the government that it will be able to supply around 22 crore doses of Covishield in October.

Read More

IIL To Make 10 Million Doses Of Covaxin Drug Substance From December

Lauding the efforts of the PSU for its ability to roll out the vaccine drug substance in record time, Union Minister Parshottam Rupala formally handed over the drug substance to Bharat Biotech, makers of Covaxin

Read More

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials

On the production levels of Covaxin, Ella said 100 million doses per month can be possible if the other manufacturing partners are fully geared up with safety and other parameters are in place.

Read More

Bharat Biotech Awaits Feedback From WHO For Covaxin Emergency Use Listing

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on approval process and its timelines

Read More

WHO's Approval For Covaxin Likely This Month

Covaxin is one of the six vaccines that have received emergency use authorisation from India's drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.

Read More

ABB Commissions ACS560 Drives At Bharat Biotech''s Facility For Safe Manufacturing Of Covaxin

The drives are also installed at other pharmaceutical companies in India, which are manufacturing COVID-19 vaccines for the country

Read More

Gujarat: First Commercial Batch Of Covaxin Released From Bharat Biotech's New Plant

The government had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

Read More

Vaccines For Children May Be Available By September: National Institute Of Virology

Hopefully the results will be available soon and they will be presented to regulators. Probably by September or just after September, we may have a vaccine for children this is Covaxin, says Priya Abraham, Director of the National Institute of Virology

Read More

Mixing Of Covaxin & Covishield: Efficacy Check

The puzzling question that is arising as of now is about the contrasting effects of the two vaccines on protection and potency.

Read More

Govt Approves Bharat Biotech's Ankleshwar Plant To Produce Covaxin: Mandaviya

The approval would help increase availability of COVID-19 vaccines in the country, he added.

Read More

Only Marginal Difference In Purchase Price Of Covishield, Covaxin For Centre: MoS Health

The total doses of vaccine that would be available to a state and UT, is provided to them 15 days in advance, so as to enable them to plan for acceleration of vaccination coverage while being cognizant of the available vaccines

Read More

Bharat Biotech Scraps Mou With Brazilian Partners After Graft Allegations

Bharat Biotech signed a MoU with Precisa Medicamentos and Envixia Pharmaceuticals LL.C on November 20 for the purpose of introducing Covaxin in the territory of Brazil.

Read More